IRIS
BIANCONI, MARISTELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.207
EU - Europa 1.433
AS - Asia 1.208
SA - Sud America 375
AF - Africa 104
Continente sconosciuto - Info sul continente non disponibili 100
OC - Oceania 1
Totale 6.428
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.147
SG - Singapore 405
IT - Italia 312
BR - Brasile 309
VN - Vietnam 224
CN - Cina 223
RU - Federazione Russa 205
UA - Ucraina 200
DE - Germania 129
SE - Svezia 129
TR - Turchia 112
IE - Irlanda 107
FI - Finlandia 82
DK - Danimarca 75
HK - Hong Kong 74
FR - Francia 69
GB - Regno Unito 63
KR - Corea 42
CI - Costa d'Avorio 38
IN - India 36
CA - Canada 29
MA - Marocco 28
BD - Bangladesh 27
MX - Messico 21
AR - Argentina 20
ZA - Sudafrica 17
JP - Giappone 14
NL - Olanda 14
ES - Italia 13
CO - Colombia 11
EC - Ecuador 10
ID - Indonesia 10
BE - Belgio 8
CL - Cile 8
PL - Polonia 8
VE - Venezuela 8
IQ - Iraq 7
MY - Malesia 7
DZ - Algeria 6
TN - Tunisia 5
EU - Europa 4
PK - Pakistan 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
HN - Honduras 3
KE - Kenya 3
LT - Lituania 3
RS - Serbia 3
SA - Arabia Saudita 3
SC - Seychelles 3
AT - Austria 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
UZ - Uzbekistan 2
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
EG - Egitto 1
IM - Isola di Man 1
KG - Kirghizistan 1
LB - Libano 1
MD - Moldavia 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
TH - Thailandia 1
TV - Tuvalu 1
Totale 6.332
Salva come PNG Salva come JPEG
Città #
Ashburn 545
Singapore 252
Chandler 236
Fairfield 217
Jacksonville 207
Dallas 154
San Jose 153
Wilmington 137
Council Bluffs 110
Dublin 107
Seattle 98
Centro 96
Boardman 94
New York 84
Woodbridge 83
Houston 78
Ho Chi Minh City 72
Hong Kong 70
Ann Arbor 69
Beijing 63
Cambridge 59
Hanoi 58
Los Angeles 53
Des Moines 51
Moscow 48
Lawrence 43
Princeton 43
San Mateo 43
Turin 43
Lauterbourg 38
Abidjan 37
The Dalles 36
Munich 29
Helsinki 23
Turku 21
Orem 20
São Paulo 20
Milan 19
Chicago 18
London 17
San Diego 17
Hefei 15
Tokyo 14
Atlanta 13
Buffalo 13
Chennai 13
Johannesburg 11
Pune 10
Rio de Janeiro 10
Santa Clara 10
Columbus 9
Frankfurt am Main 9
Izmir 9
Montreal 9
Stockholm 9
Brasília 8
Brussels 8
Paris 8
Amsterdam 7
Belo Horizonte 7
Da Nang 7
Manchester 7
Poplar 7
Cagliari 6
Denver 6
Miano 6
Norwalk 6
Porto Alegre 6
San Francisco 6
Santiago 6
Shanghai 6
Warsaw 6
Wuxi 6
Brooklyn 5
Bến Tre 5
Campinas 5
Curitiba 5
Dhaka 5
Fortaleza 5
Guangzhou 5
Guayaquil 5
Kilburn 5
Mexico City 5
Rome 5
Washington 5
Wuhan 5
Biên Hòa 4
Bogotá 4
Bắc Giang 4
Duque de Caxias 4
Fayetteville 4
Goiânia 4
Grand Rapids 4
Guarulhos 4
Haiphong 4
Madrid 4
Montevideo 4
Mumbai 4
Santo André 4
Toronto 4
Totale 4.055
Salva come PNG Salva come JPEG
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 225
Immunotherapy in genitourinary cancers: Where are we going? 212
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment 203
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 199
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 197
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 197
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 187
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 175
Il profilo angiogenico nel carcinoma renale metastatico: implicazioni prognostiche e terapeutiche 173
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 172
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 168
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 165
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 164
Neutrophil‑to‑lymphocyte ratio may be associated with the outcome in patients with prostate cancer 162
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 159
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 159
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 159
Adjuvant treatment after surgical resection 158
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 157
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 156
Panitumumab for the treatment of metastatic colorectal cancer: A review 151
Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer. 146
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 146
Beyond RAS: the role of epidermal growth factor receptor (EGFR) and its network in the prediction of clinical outcome during anti-EGFR treatment in colorectal cancer patients 144
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 143
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 141
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 140
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 139
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 137
Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer 135
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 134
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 132
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 132
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 131
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 128
Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: It is not about the destination, it is about the journey 119
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 111
Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study. 111
VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinoma 109
The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy 100
Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice 92
State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors. 87
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma 73
Totale 6.428
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.295
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.295
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022243 0 0 4 5 2 19 21 22 18 53 29 70
2022/2023727 53 98 59 48 47 114 1 38 166 3 83 17
2023/2024364 61 2 29 45 54 93 6 11 1 6 8 48
2024/2025833 112 74 10 12 47 29 120 32 139 62 109 87
2025/20262.337 158 226 166 236 293 170 357 199 165 212 55 100
2026/2027187 89 59 39 0 0 0 0 0 0 0 0 0
Totale 6.428